INVITRO ACTIVITY OF THE NEW QUINOLONE RO-23-6240 (AM-833) AND THE NEW CEPHALOSPORINS RO-15-8074 AND RO-19-5247 (T-2525) AGAINST MYCOBACTERIUM-FORTUITUM AND MYCOBACTERIUM-CHELONAE

被引：7

作者：

HOHL, P ^{[1
]}

SALFINGER, M ^{[1
]}

KAFADER, FM ^{[1
]}

机构：

[1] UNIV ZURICH, DEPT MED MICROBIOL, CH-8006 ZURICH, SWITZERLAND

来源：

关键词：

D O I：

10.1007/BF02013118

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：487 / 488

页数：2

共 6 条

[1] BETA-LACTAM ANTIBIOTICS AND MYCOBACTERIA [J].

FINCH, R .

GAY, JD ;

DEYOUNG, DR ;

ROBERTS, GD .

[3]

Sommers HM, 1985, MANUAL CLIN MICROBIO, P216

[4]

SWENSON JM, 1985, ANTIMICROB AGENTS CH, V28, P807, DOI 10.1128/AAC.28.6.807

SWENSON, JM ;

THORNSBERRY, C ;

SILCOX, VA .

[6]

VESTAL AL, 1975, PROCEDURES ISOLATION, P97